Then, CCL2 recruits monocytes to the lung and subsequently form a pulmonary PMN characterized by monocytes, high infiltration of macrophages, immunosuppression, and enhanced vascular permeability, ultimately accelerating the formation of breast cancer lung metastasis (39). Here, CCL2 is linked to breast carcinoma.